Kevin Michael O'Neill - 01 Mar 2025 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Role
CEO, PDx
Signature
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Issuer symbol
GEHC
Transactions as of
01 Mar 2025
Net transactions value
-$132,859
Form type
4
Filing time
05 Mar 2025, 19:44:05 UTC
Previous filing
04 Feb 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GEHC Common Stock, par value $0.01 per share Tax liability $132,859 -1,521 -7.7% $87.35 18,354 01 Mar 2025 Direct F1
transaction GEHC Common Stock, par value $0.01 per share Award $0 +4,626 +25% $0.000000 22,980 03 Mar 2025 Direct F2, F3
holding GEHC Common Stock, par value $0.01 per share 59 01 Mar 2025 By share incentive plan trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GEHC Employee Stock Option (right to buy) Award $0 +13,231 $0.000000 13,231 03 Mar 2025 Common Stock, par value $0.01 per share 13,231 $86.45 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
F2 Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
F3 Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028.
F4 Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions.